文献速递瓣膜病与结构性心脏病

两代球囊扩张式经导管心脏瓣膜的血流动力学差异

Haemodynamic differences between two generations of a balloon-expandable transcatheter heart valve.
PubMed 文献 · Heart · 2022-08-25

本研究基于多中心RhineHeart TAVI注册研究,比较了SAPIEN 3 Ultra与SAPIEN 3两款经导管心脏瓣膜术后血流动力学及30天临床结局。共纳入697例患者(S3 Ultra组314例,S3组383例),S3 Ultra组术后平均跨瓣压差显著更高(14.2±4.8 vs 10.2±4.4 mm Hg,p<0.01),多因素分析及倾向性评分匹配均证实此关联。两组30天死亡率、心肌梗死、永久起搏器植入及血管并发症无差异。

要点

  • S3 Ultra术后平均跨瓣压差显著高于S3(14.2±4.8 vs 10.2±4.4 mm Hg)。
  • 多因素回归及倾向性评分匹配均显示S3 Ultra与更高跨瓣压差相关(p<0.01)。
  • 两组30天死亡率、心梗、起搏器植入及血管并发症无显著差异。

核心结论

  • 与SAPIEN 3相比,SAPIEN 3 Ultra经导管心脏瓣膜术后平均跨瓣压差更高,但30天死亡及不良临床事件无差异。

研究设计与样本

  • 多中心RhineHeart TAVI注册研究,纳入697例接受TAVI的患者(S3 Ultra组314例,S3组383例),比较术后血流动力学及30天临床结局,采用多因素分析和倾向性评分匹配。

主要发现

  • S3 Ultra组术后平均跨瓣压差为14.2±4.8 mm Hg,S3组为10.2±4.4 mm Hg,差异有统计学意义(p<0.01)。
  • 多因素logistic回归及倾向性评分匹配均显示使用S3 Ultra与更高的术后平均跨瓣压差相关(p<0.01)。
  • 两组30天死亡率、心肌梗死、永久起搏器植入及血管并发症发生率相当。

临床怎么用

  • 选择SAPIEN 3 Ultra时需注意其术后跨瓣压差可能高于SAPIEN 3,应结合患者个体情况评估血流动力学影响。
  • 尽管早期临床结局相似,仍需长期随访评估跨瓣压差差异的临床相关性。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to investigate early haemodynamic and clinical performance of the SAPIEN 3 Ultra (S3 Ultra) transcatheter heart valve (THV) system in comparison to its precursor, the SAPIEN 3 (S3). Previous studies have indicated potential haemodynamic differences between the S3 Ultra and S3. Such differences may impact clinical outcome after transcatheter aortic valve implantation (TAVI). METHODS: Postprocedural haemodynamic performance and 30-day clinical outcome were compared in patients who underwent TAVI receiving either the S3 or the new S3 Ultra prostheses. Multivariable analysis and propensity score matching (PSM) were used to identify factors associated with higher mean transvalvular gradients. RESULTS: We included 697 patients (S3 Ultra: n=314, S3: n=383) from the multicentre RhineHeart TAVI Registry. Patients receiving the S3 Ultra prosthesis showed significantly higher postprocedural mean transvalvular gradients (14.2±4.8 vs 10.2±4.4 mm Hg; p<0.01). Multivariable logistic regression analyses and additional PSM revealed the use of the S3 Ultra to be associated with higher postprocedural mean transvalvular gradients (p<0.01). 30-day clinical outcomes, such as mortality, myocardial infarction, permanent pacemaker implantation and vascular complications were comparable between the groups. CONCLUSIONS: The new S3 Ultra THV was associated with a higher postprocedural mean transvalvular gradient compared with the S3 system, while there was no difference in mortality or adverse clinical outcomes at 30 days. These echocardiographic differences will require long-term studies to assess the clinical relevance of this finding.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Wilde N, Rogmann M, Mauri V, et al. Haemodynamic differences between two generations of a balloon-expandable transcatheter heart valve. Heart. 2022. PMID: 35039329. doi:10.1136/heartjnl-2021-320084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。